Medinotec Inc. revenue by segment MDNC

Medinotec Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2026, which ended Feb 28, 2026 was Outside USA Distribution Agreement Sales at $8.1 million, 84% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2027
Aug 31, 2026
FY 2026
Feb 28, 2026
FY 2025
Feb 28, 2025
FY 2024
Feb 29, 2024
FY 2023
Feb 28, 2023
Revenue
10
10
9
5
1
Outside USA Distribution Agreement Sales
9
-12.6%
share 83.5%
8
+7.5%
share 83.7%
8
+117.0%
share 83.1%
3
share 69.5%
—
Outside The United States
—
—
—
—
1
share 97.9%
Outside USA Internally Designed Manufactured Sales
1
-13.4%
share 8.5%
1
+13.0%
share 10.0%
1
-11.6%
share 9.5%
1
-0.2%
share 19.4%
1
share 97.9%
Inside USA Internally Designed Manufactured Sales
1
+22.8%
share 7.9%
1
-9.8%
share 6.3%
1
+22.4%
share 7.4%
1
+2480.6%
share 11.0%
0
share 2.1%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MDNC (OTC)
Fiscal year ends
February 28
Incorporated in
NV
Headquarters
Johannesburg
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1931055

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.